Profile photo

Lung Cancers Today

Pulmonology

Lung Cancers Today features breaking news, commentary, expert interviews, and more for practicing oncologists treating lung malignancies.

STS 2025: Unpacking Key Updates in Lung Cancer

Dear readers,

The 61st Annual Meeting of the Society of Thoracic Surgeons, which took place late last month, featured key updates on the surgical landscape for lung cancer.

From real-world data on sublobar resection versus lobectomy in non-small cell lung cancer, to an entire session devoted to operating in stage IV lung cancer, the meeting addressed many hot topics and pressing questions in the field. Don’t miss our interview with Mara B. Antonoff, MD, FACS, who shares key insights from the session on operating in stage IV lung cancer and what the future may hold.

Beyond the conference, we’re also proud to highlight our new interview on the formation of the ALK Positive Scientific Advisory Board; an insightful interview with Stephen Liu, MD, who discusses the implications of the recent MARIPOSA overall survival data; and more.

Looking for more lung cancer news and insights? Check out our website for daily updates on research, treatment, regulatory approvals, and more.

Until next time,
Lung Cancers Today Editors

Articles
  • Mashup Score: 0
    ALK Positive Announces Formation of Scientific Advisory Board | Docwire News - 5 month(s) ago

    Read the full article here

    Tweet Tweets with this article
    • Profile photo of Lung_Cancers
      Lung_Cancers

      ⭐ Today, @ALKPositiveinc announced the formation of its Scientific Advisory Board! 🗨️ Don't miss this insightful interview about the new board with ALK Positive President Kirk Smith & Dr. Ken Culver, Director of Research & Clinical Affairs! ➡️ Watch: https://t.co/FV3wWGEKnh https://t.co/ej0pyLOEkY

  • Mashup Score: 1
    EMA CHMP Recommends Durvalumab for Limited-Stage SCLC | Docwire News - 5 month(s) ago

    Read the full article here

    Tweet Tweets with this article
    • Profile photo of Lung_Cancers
      Lung_Cancers

      📰 REGULATORY UPDATE: The EMA CHMP has recommended durvalumab as a monotherapy for adults with LS-SCLC whose disease has not progressed following platinum-based chemoradiation therapy. ➡️ Learn more: https://t.co/jTLtdbm2LJ #SCLC #lcsm #LungCancer https://t.co/o0BfCDJ8Eb